There is a growing need for bioassays that can accurately characterize the various aspects of biopharmaceutical drugs in the pharmaceutical industry. Developing these bioassays is a complex and rigorous process that involves addressing multiple challenges, such as modeling the mechanisms of action associated with biotherapeutics and ensuring the development of robust and validatable assays.
Assay-ready reporter gene assays are an invaluable tool in assessing both functionality and representing the mode of action (MOA) in bioassays.
In this poster, we have outlined a set of assays by which the performance of cell-based reporter gene assays can be determined and validated. To ensure that the assays are reliable, accurate, and reproducible and that errors resulting from biological variation and methodology are kept to a minimum.
